Seizures induced by desloratadine, a second-generation antihistamine: Clinical observations

Neuropediatrics

Volumn 44, Issue 4, 2013, Pages 222-224

  Cerminara, Caterina ^a   El Malhany, Nadia ^a   Roberto, Denis ^a   Lo Castro, Adriana ^a   Curatolo, Paolo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

antihistamine; desloratadine; epilepsy; seizure

Indexed keywords

DESLORATADINE; VALPROIC ACID;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CHILD; CHILDHOOD ABSENCE EPILEPSY; CLINICAL OBSERVATION; DISEASE FREE INTERVAL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FAMILY HISTORY; FEBRILE CONVULSION; FEMALE; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; MALE; MYOCLONUS SEIZURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SEIZURE; SEIZURE SUSCEPTIBILITY; SPIKE WAVE; TIC; TONIC CLONIC SEIZURE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYPERSENSITIVITY; LORATADINE; MALE;

EID: 84880325726     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0033-1333871     Document Type: Article

References (15)

1. Yamashita Y., Isagai T., Seki Y., Ohya T., Nagamitsu S., Matsuishi T. West syndrome associated with administration of a histamine H1 antagonist, oxatomide. Kurume Med J: 2004; 51 3-4 273 275 (Pubitemid 40202388)
2. Chen Z., Li Z., Sakurai E., et al. Chemical kindling induced by pentylenetetrazol in histamine H(1) receptor gene knockout mice (H(1)KO), histidine decarboxylase-deficient mice (HDC(-/-)) and mast cell-deficient W/W(v) mice. Brain Res: 2003; 968 1 162 166 (Pubitemid 36315685)
3. Estelle F., Simons R. H1-receptor antagonists: safety issues. Ann Allergy Asthma Immunol: 1999; 83 5 481 488
4. Shimoda Y., Koizumi A., Tanaka K. Electroencephalographic activation of "diencephalic epilepsyo" with diphenhydramine. Yonago Acta Med: 1960; 4 99 102
5. Yasuhara A., Ochi A., Harada Y., Kobayashi Y. Infantile spasms associated with a histamine H1 antagonist. Neuropediatrics: 1998; 29 6 320 321 (Pubitemid 29054568)
6. Simons F. E., Simons K. J. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol: 2011; 128 6 1139 1150, e4
7. Welch M. J., Meltzer E. O., Simons F. E. H1-antihistamines and the central nervous system. Clin Allergy Immunol: 2002; 17 337 388
8. Berger W. E. The safety and efficacy of desloratadine for the management of allergic disease. Drug Saf: 2005; 28 12 1101 1118 (Pubitemid 41776001)
9. Parsons M. E., Ganellin C. R. Histamine and its receptors. Br J Pharmacol: 2006; 147 01 S127 S135 (Pubitemid 43077270)
10. Jiang X., Chen A., Li H. Histaminergic modulation of excitatory synaptic transmission in the rat basolateral amygdala. Neuroscience: 2005; 131 3 691 703 (Pubitemid 40261224)
11. Swiader M., Wielosz M., Czuczwar S. J. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol: 2004; 14 4 307 318 (Pubitemid 38649088)
12. Kamei C. Involvement of central histamine in amygdaloid kindled seizures in rats. Behav Brain Res: 2001; 124 2 243 250 (Pubitemid 32964642)
13. Mimura N., Nagata Y., Kuwabara T., Kubo N., Fuse E. P-glycoprotein limits the brain penetration of olopatadine hydrochloride, H1-receptor antagonist. Drug Metab Pharmacokinet: 2008; 23 2 106 114
14. Chen C., Hanson E., Watson J. W., Lee J. S. P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists. Drug Metab Dispos: 2003; a 31 3 312 318 (Pubitemid 36249686)
15. Wang E. J., Casciano C. N., Clement R. P., Johnson W. W. Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein. Drug Metab Dispos: 2001; 29 8 1080 1083 (Pubitemid 32660524)